Sentences with phrase «potential cell source»

The successful differentiation of iPS cells into RPE represents a significant advance in the search for a potential cell source for the treatment of human neural retinal diseases.

Not exact matches

Rare earth minerals, the 17 elements used in high - tech products such as cell phones and hybrid vehicles, represent another potential source of growth for Canadians over time.

What Stephen Hawking Missed: Small Biotechs Developing Promising Cell Therapies for Devastating Disease Source: Streetwise Reports (5/2/18) In the second of a two - part series exploring the disruptive cell therapy space, Maxim Group analyst Jason McCarthy takes a look at small - cap companies targeting big - ticket indications and their potential to drive blockbuster value for both patients and investCell Therapies for Devastating Disease Source: Streetwise Reports (5/2/18) In the second of a two - part series exploring the disruptive cell therapy space, Maxim Group analyst Jason McCarthy takes a look at small - cap companies targeting big - ticket indications and their potential to drive blockbuster value for both patients and investcell therapy space, Maxim Group analyst Jason McCarthy takes a look at small - cap companies targeting big - ticket indications and their potential to drive blockbuster value for both patients and investors.

Breastmilk is a novel source of stem cells with multilineage differentiation potential.

«This research has broad impact, because by deepening our understanding of cell reprogramming we have the potential to improve disease modeling and the generation of better sources of patient - specific specialized cells suitable for replacement therapy,» said Plath.

Clinical trials that charge enrollees to participate are ostensibly aimed at giving patients early access to promising therapies — often in the fields of stem cells or aging reversal — that are too unusual or have too little profit potential to get funding from traditional sources such as companies, foundations, or the National Institutes of Health.

A patient's own bone marrow stem cells are, however, a valuable source of potential treatment as they can generate joint tissue the body will not reject when re-implanted.

«Induced pluripotent stem cells have tremendous potential as a source for personalized cellular therapeutics for organ repair,» said Joseph Wu, MD, PhD, director of the Stanford Cardiovascular Institute.

This causes the material to have great potential as a back reflector to enhance the efficiency of solar cells or tiny on - chip light sources.

Clinicians have a potential source of neural cells for treating stroke or Parkinson?s victims, and pancreas cells for treating diabetes patients.

Seeking fresh sources, they looked for cells that express the gene neurogenin 3, a potential sign of cell differentiation because it is the first gene to only switch on in pancreatic islets during embryonic development.

That still makes them a potential source of ES cells, and because human parthenote embryos can't develop to term, some people have fewer qualms about using them to produce stem cells.

«This work has the potential to provide a novel source of abundant, easily accessible and autologous cells for treatment of devastating neurodegenerative diseases.

After hearing a brief explanation that laid out the different sources of stem cells (but left undiscussed their current uses or future potential for therapy), the respondents offered a slightly more nuanced set of views, and only a slight majority (52 %) supported embryonic stem cell research.

Researchers assessing the cardiac differentiation potential of several adipose - derived stem cells describe an optimal cell source

The cells generated in the Zeng lab may not only provide a potential unlimited source for cell replacement therapy for Parkinson's disease, but also offer an unprecedented opportunity to develop screening models for assessing small molecule drugs and to clarify the mechanisms of disease.

The introduction of genetic markers makes it possible to isolate such cells from different sources and to examine their therapeutic potential.

Our Areas of Interest IFATS current scientific areas of interest relate to facilitating the development of treatments for excess body fat, the generation of new fat tissue for reconstruction after cancer or birth - related defects and the use of adipose tissue as a source of mesenchymal stem cells that have the potential to regenerate and repair different body tissues.

Cymerus is a patented stem cell manufacturing process that avoids the problems often associated with deriving MSCs and primary tissue sources, and has the potential to generate large - scale, low - cost MSCs based on a single blood donation from one adult donor.

It will focus on catalyst development for four applications: proton exchange membrane fuel cells to convert stored energy in non-fossil fuels into electricity; electrolysers for splitting water into oxygen and hydrogen — a potential clean fuel cell source; syngas, a mixture of CO and H2, which is generated from coal, gas and biomass, and widely used as a key intermediate in the chemical industry; and lithium - air batteries.

Stem cells are the most favorable cell source for cell therapy, due to their inherent self - renewal properties and differentiation potential.

«I highly respect Novocell technologies and am pleased to collaborate with Novocell and explore the potential of their hES cell to islet cell advances in combination with our iPS cells as a potential new sources for the generation of cellular models and therapies for diabetes,» said Dr. Yamanaka, Director of Center for iPS Research and Application at Kyoto University.

«This discovery will advance our understanding of stem cell epigenetics and chromatin structures, provide potential mechanisms on maintaining the hallmark properties of ES cells, and help researchers with the rich source of information to better understand some of the unique features — such as self - renewal and pluripotency — of human embryonic stem cells,» said Ng Huck Hui, Ph.D., senior group leader at GIS and a member of the Singapore team that conducted this research.

Also, pESC lines, that carry isogenic genome information from the oocyte donors, can be derived and may represent a potential alternative source of stem cells for basic scientific studies as well as novel therapeutic application.

Quiñones - Hinojosa A, Chaichana K. «The human subventricular zone: a source of new cells and a potential source of brain tumors».

This pluripotency makes hPSCs a potential source of renewable, healthy, specialized cells for use in transplantation and the treatment of a wide variety of diseases and injuries such as heart disease, Parkinson's and burns.

In sum, human NSCs represent an invaluable source of cells to investigate human iPS induction, and also represent a potential source of cells for deriving patient - specific pluripotent stem cells for modeling human disease.

«Human Source Of Stem Cells With Potential To Repair Muscle Identified.»

The routine use of MSC cellular therapy with would benefit from a uniform cell source, with stable phenotype and function as well as providing a solution to potential safety issues.

Human placenta and chorion: potential additional sources of hematopoietic stem cells for transplantation.

Alternatively, embryonic stem (ES) cells have emerged as a potential source of less immunogenic hematopoietic progenitor cells (HPCs).

Using cloning technology to derive embryonic stem cells genetically identical to a patient is potentially very important, not only to provide a source of cells that may be used to cure patients, but also to allow for genetic disease to be studied and potential drug treatments to be explored in the laboratory.

These findings, published recently by the high - impact journal Nanoscale («Tessellated gold nanostructures from Au144 (SCH2CH2Ph) 60 molecular precursors and their use in organic solar cell enhancement»), represent a game - changing innovation that holds the potential to take solar power mainstream and dramatically decrease the world's dependence on traditional, resource - based sources of energy, says Giovanni Fanchini from Western's Faculty of Science.

Thus, in the past five years, much of the scientific and ethical debate about somatic cell nuclear transfer has focused on its two potential applications: 1) for reproductive purposes, i.e., to produce a child, or 2) for producing a source of ES cells for research.

«Hydrogen fuel cells as a power source have the potential to bring to the force incredibly valuable capabilities,» said TARDEC Director Paul Rogers.

Solar cells have great potential as a source of clean electrical energy, but so far they have not been cheap, light, and flexible enough for widespread use.

The facility has the potential to provide all its heating, cooling and energy needs and even an energy surplus, from solar and geothermal sources and a fuel cell with advanced energy - management controls.

Researchers recently invented a power cell that harnesses algae energy, a potential renewable energy source to help reduce fossil fuel dependence.

The interesting thing about the physics of plasma double layers is that they are regions defined by charge separation that enshroud matter immersed in a cell of plasma, and the electric potential drop occurs within the double layer itself, so if we have a solar source that is positively charged, for example, and an earth that is negatively charged, then the electric potential drop is not between the anodic sun and the cathodic earth themselves, but within the plasma double layer shrouding the earth from its plasma environment.

However welcome the recent announcement that a team of scientists based at Newcastle University, has grown a section of human liver using stem cells from umbilical cords, rather than from the more controversial source of embryonic stem cells, and whatever the eventual promise or potential of harvesting organs for transplantation from genetically modified pigs, the benefits of either of these two pioneering techniques to currently dying / suffering patients, remain both elusive and distant.